Abstract
Abstract The purpose of this study was to evaluate the effects of the clinical use of probiotic therapy in any serum inflammatory markers in individuals with any inflammatory process. A systematic review with meta-analysis approach was used to analyze randomized controlled trials (RCTs) studies from PubMed/MEDLINE, EMBASE and Cochrane Library databases. The most commonly used probiotic bacteria were those of the genus Lactobacillus spp. and the treatment time of the studies ranged from 1 to 52 weeks. Six studies reported an increase on anti-inflammatory markers and forty-five studies reported a decrease on pro-inflammatory markers. Meta-analysis indicated that probiotics reduced Tumor Necrosis Factor-α [standardized mean difference (SMD): −10.65; 95% CI: −25.20, −6.10; I2 = 100%; P
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
